Robert Buynak

Efficacy and safety of tapentadol extended release for the management of chronic low back pain: results of a prospective, randomized, double-blind, placebo- and active-controlled Phase III study

Robert Buynak, Douglas Y. Shapiro, Akiko Okamoto et al. · Expert Opinion on Pharmacotherapy · 2010 · 250 citations

Medicine, Pharmacotherapy, Clinical Pharmacology +16

Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in major depressive disorder (MDD) in patients with an inadequate response to ongoing antidepressant treatment: a multicentre, randomized, double-blind, placebo-controlled study

Nizar El-Khalili, Mark Joyce, Sarah Atkinson et al. · The International Journal of Neuropsychopharmacology · 2010 · 184 citations · Full text

Pharmacy, Pharmacotherapy, Psychiatry +17

RNA Interference With Zilebesiran for Mild to Moderate Hypertension

George L. Bakris, Manish Saxena, Anil Gupta et al. · JAMA · 2024 · 116 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +17

Safety, Immunogenicity, and Efficacy of the NVX-CoV2373 COVID-19 Vaccine in Adolescents

Germán Áñez, Lisa M. Dunkle, Cynthia L. Gay et al. · JAMA Network Open · 2023 · 50 citations · Full text

Veterinary Medicine, Infectious Diseases, Pediatrics +17

Long-term Safety and Efficacy of Tapentadol Extended Release Following up to 2 Years of Treatment in Patients With Moderate to Severe, Chronic Pain: Results of an Open-label Extension Trial

Robert Buynak, Stephen A. Rappaport, Kevin Rod et al. · Clinical Therapeutics · 2015 · 43 citations

Nursing, Pharmacotherapy, Pain Management +13